ADIAL PHARMACEUTICALS, INC. (ADIL)
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
Electromed Announces CEO’s Planned Retirement
Pega to Present at Upcoming Investor Conference
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
OppFi to Participate in September 2026 Conferences
SL Green Realty Corp. to Present at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026
Zoom Communications Reports Financial Results for the Second Quarter of Fiscal Year 2027
NextNav to Participate in HC Wainwright Global Investor Conference
Mission Produce® to Release Fiscal Third Quarter 2026 Financial Results on Tuesday, September 8, 2026
ABM to Announce Third Quarter 2026 Financial Results
Zillow Group to present at Goldman Sachs Communacopia + Technology Conference
Box Reports Second Quarter Fiscal 2027 Financial Results
Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
Upstart Co-founder and CEO to Participate in Fireside Chat at the Goldman Sachs Communacopia and Technology Conference 2026